Cargando…

Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancer

Prostate-associated gene 4 (PAGE4) is a remarkably prostate-specific Cancer/Testis Antigen that is highly upregulated in the human fetal prostate and its diseased states but not in the adult normal gland. PAGE4 is an intrinsically disordered protein (IDP) that functions as a stress-response protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulkarni, Prakash, Dunker, A Keith, Weninger, Keith, Orban, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000790/ https://www.ncbi.nlm.nih.gov/pubmed/27270343 http://dx.doi.org/10.4103/1008-682X.181818

Ejemplares similares

Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target
por: Salgia, Ravi, et al.
Publicado: (2018)

Intrinsically disordered proteins and prostate cancer: pouring new wine in an old bottle
por: Kulkarni, Prakash
Publicado: (2016)

Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins
por: Mooney, Steven M, et al.
Publicado: (2016)

Cancer/Testis Antigen PAGE4, a Regulator of c-Jun Transactivation, Is Phosphorylated by Homeodomain-Interacting Protein Kinase 1, a Component of the Stress-Response Pathway
por: Mooney, Steven M., et al.
Publicado: (2014)

Unfoldomics of prostate cancer: on the abundance and roles of intrinsically disordered proteins in prostate cancer
por: Landau, Kevin S, et al.
Publicado: (2016)

Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity
por: Jolly, Mohit Kumar, et al.
Publicado: (2018)

Molecular signaling involving intrinsically disordered proteins in prostate cancer
por: Russo, Anna, et al.
Publicado: (2016)

Cancer/Testis Antigens: “Smart” Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers
por: Kulkarni, Prakash, et al.
Publicado: (2017)

CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers
por: Kim, John J, et al.
Publicado: (2013)

Cancer-cell-intrinsic mechanisms shaping the immunosuppressive landscape of prostate cancer
por: Zhu, Yini, et al.
Publicado: (2022)

Illuminating Intrinsically Disordered Proteins with Integrative Structural Biology
por: Evans, Rachel, et al.
Publicado: (2023)

Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy
por: Shiraishi, Takumi, et al.
Publicado: (2011)

The path forward in prostate cancer therapeutics
por: Aragon-Ching, Jeanny B, et al.
Publicado: (2018)

Single Molecule FRET: A Powerful Tool to Study Intrinsically Disordered Proteins
por: LeBlanc, Sharonda J., et al.
Publicado: (2018)

The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014)

Per Aspera ad Chaos: Vladimir Uversky’s Odyssey through the Strange World of Intrinsically Disordered Proteins
por: Kulkarni, Prakash, et al.
Publicado: (2023)

Inducible expression of cancer-testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2016)

Multiple therapeutic and preventive effects of 3,3′-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia
por: Zhang, William Weiben, et al.
Publicado: (2014)

Structural and Dynamical Order of a Disordered Protein: Molecular Insights into Conformational Switching of PAGE4 at the Systems Level
por: Lin, Xingcheng, et al.
Publicado: (2019)

Coupled Feedback Loops Involving PAGE4, EMT and Notch Signaling Can Give Rise to Non-Genetic Heterogeneity in Prostate Cancer Cells
por: Singh, Divyoj, et al.
Publicado: (2021)

The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2020)

Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
por: Tateishi, Ukihide
Publicado: (2020)

Heat shock and other apoptosis-related proteins as therapeutic targets in prostate cancer
por: Albany, Costantine, et al.
Publicado: (2014)

Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications
por: Singh, B Harpreet, et al.
Publicado: (2014)

Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting
por: Kumar, Raj
Publicado: (2016)

Inducible expression of antigen processing and antigen presentation molecules and cancer testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2015)

Prostate cancer stem cells
por: Lang, SH, et al.
Publicado: (2009)

Role of chemotherapy in prostate cancer
por: Nader, Rita, et al.
Publicado: (2018)

Vitamin D in prostate cancer
por: Trump, Donald L, et al.
Publicado: (2018)

Characterization of Intrinsically Disordered Prostate Associated Gene (PAGE5) at Single Residue Resolution by NMR Spectroscopy
por: Hellman, Maarit, et al.
Publicado: (2011)

Separate Chinese lines for prostate cancer?
por: von Eyben, Finn Edler
Publicado: (2019)

Impact of IL-23 in prostate cancer
por: Mirlekar, Bhalchandra
Publicado: (2021)

Derepression of Cancer/Testis Antigens in cancer is associated with distinct patterns of DNA Hypomethylation
por: Kim, Robert, et al.
Publicado: (2013)

Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update
por: Mooney, Steven M, et al.
Publicado: (2016)

What is the next generation therapeutic strategy for castration-resistant prostate cancer
por: Wen, Si-Meng, et al.
Publicado: (2015)

Glucocorticoids and prostate cancer treatment: friend or foe?
por: Montgomery, Bruce, et al.
Publicado: (2014)

Optimal treatment for castration-resistant prostate cancer
por: Izumi, Kouji, et al.
Publicado: (2014)

Perspectives on the clinical management of localized prostate cancer
por: Nelson, Joel B
Publicado: (2014)

The role of mRNA splicing in prostate cancer
por: Lapuk, Anna V, et al.
Publicado: (2014)

Current early diagnostic biomarkers of prostate cancer
por: Qu, Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sjd5mlmjsaq8dgh8j4vfl6pv9r